1 | 15509163 | 4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships. | J Med Chem | 2004 Nov 4 |
2 |
2 | 18325637 | Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III). | Eur J Med Chem | 2008 Nov |
1 |
3 | 22336385 | 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence. | Eur J Med Chem | 2012 Apr |
1 |
4 | 22512552 | Melatonin synthetic analogs as nitric oxide synthase inhibitors. | Mini Rev Med Chem | 2012 Jun |
1 |
5 | 22583669 | Synthesis, biological evaluation and 3D-QSAR studies of novel 4,5-dihydro-1H-pyrazole niacinamide derivatives as BRAF inhibitors. | Bioorg Med Chem | 2012 Jun 15 |
2 |
6 | 22985957 | Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors. | Bioorg Med Chem | 2012 Oct 15 |
2 |
7 | 22985962 | Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase. | Bioorg Med Chem | 2012 Oct 15 |
3 |
8 | 23735830 | Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group. | Bioorg Med Chem | 2013 Jul 15 |
4 |
9 | 25496804 | Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors. | Bioorg Med Chem | 2015 Jan 1 |
2 |
10 | 25541201 | Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors. | Bioorg Med Chem | 2015 Feb 1 |
2 |
11 | 26293971 | Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives. | Arch Pharm (Weinheim) | 2015 Oct |
1 |
12 | 28676270 | Synthesis of novel 2-pyrazoline analogues with potent anti-inflammatory effect mediated by inhibition of phospholipase A2: Crystallographic, in silico docking and QSAR analysis. | Bioorg Med Chem Lett | 2017 Aug 15 |
1 |